Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz has issued a directive to all 50 U.S. governors, urging immediate action to address what he describes as rampant Medicaid fraud costing American taxpayers billions of dollars annually [1]. In letters sent Thursday morning, Dr. Oz instructed state leaders to identify and remove noncompliant Medicaid providers, emphasizing the urgency of the situation and the need for swift enforcement [1].
Dr. Oz has set a 10-business-day deadline for governors and state Medicaid leaders to inform CMS whether they will commit to a rapid 'revalidation' of high-risk Medicaid providers, along with a proposed timetable for this process [1]. Additionally, states are required to submit, within 30 days, a broader two-year strategy outlining how they will review healthcare providers for legitimacy and compliance [1]. Failure to commit to the revalidation plan will be considered in CMS's evaluation of each state's likelihood of fraud moving forward [1].
The letters specifically target providers deemed at 'high risk of waste, fraud, abuse, and corruption,' particularly those with less rigorous enrollment and billing requirements or operating without a National Provider Identifier [1]. Dr. Oz asserts that a revalidation process for high-risk providers will immediately deter criminal actors by enabling federal and state governments to closely scrutinize and, if necessary, suspend or terminate abusive providers [1].
A second letter was also sent to each state Medicaid director, reiterating the call for a state-specific revalidation strategy and emphasizing the persistent and growing threat posed by sophisticated actors exploiting Medicaid systems for financial gain [1]. Proposals from states must include a methodology and timeline for off-cycle provider reviews [1].
CONCLUSION
CMS Administrator Dr. Mehmet Oz's directive signals a significant escalation in federal efforts to combat Medicaid fraud, with strict deadlines and requirements for state action. The initiative is expected to have a high market impact, particularly for healthcare providers and state Medicaid programs, as compliance and enforcement measures intensify.